Skip to main content
SpringerLink
Log in

Carcinoid Tumors

  • Chapter
Surgical Oncology

  • 266 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Oberndorfer S. Karzinoide Tumoren des Dunndarms. Frankfurt Z Pathol 1907;1:426–430.

    Google Scholar 

  2. Gosset A, Masson P. Tumeurs endocrine de l’appendice. Presse Med 1914;22:237.

    Google Scholar 

  3. Pearse AG, Polak JM. Endocrine tumours of neural crest origin: neurolymphomas, apudomas and the APUD concept. Med Biol 1974;52:3–18.

    CAS  PubMed  Google Scholar 

  4. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813–829.

    Article  CAS  PubMed  Google Scholar 

  5. Godwin JD. Carcinoid tumors: an analysis of 2837 cases. Cancer 1975;36:560–569.

    PubMed  Google Scholar 

  6. Williams ED, Sandler M. The classification of carcinoid tumors. Lancet 1963;1:238–239.

    Article  CAS  PubMed  Google Scholar 

  7. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion 1994;55:11–23.

    PubMed  Google Scholar 

  8. Neary PC, Redmond PH, Houghton T, Watson GR, Bouchier-Hayes D. Carcinoid disease: review of the literature. Dis Colon Rectum 1997;40:349–362.

    Article  CAS  PubMed  Google Scholar 

  9. Creutzfeldt W. Carcinoid tumors: development of our knowledge. World J Surg 1996;20:126–131.

    Article  CAS  PubMed  Google Scholar 

  10. Cheng JY, Sheu LF, Meng CL, Lin JC. Expression of p53 protein in colorectal carcinoids. Arch Surg 1996;131:67–70.

    CAS  PubMed  Google Scholar 

  11. Koura AN, Giacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM. Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer 1997;79:1294–1298.

    Article  CAS  PubMed  Google Scholar 

  12. Bates HR Jr. Carcinoid tumors of the rectum: a statistical review. Dis Colon Rectum 1996;9:90.

    Google Scholar 

  13. Walton GF, Gibbs ER, Spencer GO, Laws HL. Carcinoid tumors of the ampulla of Vater. Am Surg 1997;63:302–304.

    CAS  PubMed  Google Scholar 

  14. Johnson LA, Lavin P, Moertel CG, et al. Carcinoids: the association of histologic growth pattern and survival. Cancer 1983;51:882–889.

    CAS  PubMed  Google Scholar 

  15. Soga J, Tazawa K. Pathologic analysis of carcinoids: histologic reevaluation of 62 cases. Cancer 1971;28:990–998.

    CAS  PubMed  Google Scholar 

  16. Modlin IM, Zhu Z, Tang LH, et al. Evidence for a regulatory role for histamine in gastric enterochromaffin-like cell proliferation induced by hypergastrinemia. Digestion 1996;57:310–321.

    CAS  PubMed  Google Scholar 

  17. Bordi C, D’Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995;19:S8–19.

    PubMed  Google Scholar 

  18. Modlin IM, Lawton GP, Miu K, et al. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours. Ann R Coll Surg Engl 1996;78:133–138.

    CAS  PubMed  Google Scholar 

  19. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994–1006.

    CAS  PubMed  Google Scholar 

  20. Cheng JY, Lin JC, Yu DS, Lee WH, Meng CL. Flow cytometric DNA analysis of colorectal carcinoid. Am J Surg 1994;168:29–32.

    Article  CAS  PubMed  Google Scholar 

  21. Fitzgerald SD, Meagher AP, Moniz-Pereira P, Farrow GM, Witzig TE, Wolff BG. Carcinoid tumor of the rectum: DNA ploidy is not a prognostic factor. Dis Colon Rectum 1996;39:643–648.

    Article  CAS  PubMed  Google Scholar 

  22. O’Dowd G, Gosney JR. Absence of overexpression of p53 protein by intestinal carcinoid tumours. J Pathol 1995;175:403–404.

    Article  CAS  PubMed  Google Scholar 

  23. Wang DG, Johnston CF, Anderson N, Sloan JM, Buchanan KD. Over-expression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol 1995;175:397–401.

    Article  CAS  PubMed  Google Scholar 

  24. Dietrich WF, Radany EH, Smith JS, Bishop JM, Hanahan D, Lander ES. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Proc Natl Acad Sci USA 1994;91:9451–9455.

    CAS  PubMed  Google Scholar 

  25. Wang DG, Johnston CF, Buchanan KD. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Cancer 1997;80:668–675.

    Article  CAS  PubMed  Google Scholar 

  26. Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols LK. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 1995;25:410–416.

    Article  CAS  PubMed  Google Scholar 

  27. Wilde MI, Markham A. Ondansetron: a review of its pharmacology and preliminary clinical findings in novel applications. Drugs 1996;52:773–794.

    CAS  PubMed  Google Scholar 

  28. Melnyk DL. Update on carcinoid syndrome. AANA J 1997;65:265–270.

    CAS  PubMed  Google Scholar 

  29. Ruszniewski P, Ducreux M, Chayvialle JA, et al. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 1996;39:279–283.

    CAS  PubMed  Google Scholar 

  30. Froudarakis M, Fournel P, Burgard G, et al. Bronchial carcinoids: a review of 22 cases. Oncology 1996;53:153–158.

    CAS  PubMed  Google Scholar 

  31. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998;170:1369–1373.

    CAS  PubMed  Google Scholar 

  32. Dusmet ME, McKneally MF. Pulmonary and thymic carcinoid tumors. World J Surg 1996;20:189–195.

    Article  CAS  PubMed  Google Scholar 

  33. Rea F, Binda R, Spreafico G, et al. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989;47:412–414.

    Article  CAS  PubMed  Google Scholar 

  34. Davila DG, Dunn WF, Tazelaar HD, Pairolero PC. Bronchial carcinoid tumors. Mayo Clin Proc 1993;68:795–803.

    CAS  PubMed  Google Scholar 

  35. Hoefnagel CA, Den Hartog Jager FC, Van Gennip AH, Marcuse HR, Taal BG. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine. Clin Nucl Med 1986;111:150–152.

    Google Scholar 

  36. Christin-Maitre S, Chabbert-Buffet N, Mure A, Boukhris R, Bouchard P. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. Chest 1996;109:845–846.

    CAS  PubMed  Google Scholar 

  37. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids: review of 124 cases. J Thorac Cardiovasc Surg 1985;89:8–17.

    CAS  PubMed  Google Scholar 

  38. Torre M, Barberis M, Barbieri B, Bonacina E, Belloni P. Typical and atypical bronchial carcinoids. Respir Med 1989;83:305–308.

    CAS  PubMed  Google Scholar 

  39. Okike N, Bernatz PE, Payne WS, Woolner LB, Leonard PF. Bronchoplastic procedures in the treatment of carcinoid tumors of the tracheobronchial tree. J Thorac Cardiovasc Surg 1978;76:281–291.

    CAS  PubMed  Google Scholar 

  40. Shah R, Sabanathan S, Mearns J, Richardson J, Goulden C. Carcinoid tumour of the lung. J Cardiovasc Surg 1997;38:187–189.

    CAS  Google Scholar 

  41. Chughtai TS, Morin JE, Sheiner NM, Wilson JA, Mulder DS. Bronchial carcinoid-twenty years’ experience defines a selective surgical approach. Surgery 1997;122:801–808.

    Article  CAS  PubMed  Google Scholar 

  42. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972;64:413–421.

    CAS  PubMed  Google Scholar 

  43. Kayser K, Kayser C, Rahn W, Bovin NV, Gabius HJ. Carcinoid tumors of the lung: immuno-and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol 1996;63:99–106.

    Article  CAS  PubMed  Google Scholar 

  44. Marty-Ane CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H. Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg 1995;59:78–83.

    Article  CAS  PubMed  Google Scholar 

  45. Chakravarthy A, Abrams RA. Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer 1995;75:1386–1390.

    CAS  PubMed  Google Scholar 

  46. Karmy-Jones R, Vallieres E. Carcinoid crisis after biopsy of a bronchial carcinoid. Ann Thorac Surg 1993;56:1403–1405.

    Article  CAS  PubMed  Google Scholar 

  47. Vaughan DJ, Brunner MD. Anesthesia for patients with carcinoid syndrome. Int Anesthesiol Clin 1997;35:129–142.

    CAS  PubMed  Google Scholar 

  48. Modlin IM, Sandor A, Tang LH, Kidd M, Zelterman D. A 40-year analysis of 265 gastric carcinoids. Am J Gastroenterol 1997;92:633–638.

    CAS  PubMed  Google Scholar 

  49. Roncoroni L, Costi R, Canavese G, Violi V, Bordi C. Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding. Am J Gastroenterol 1997;92:2119–2121.

    CAS  PubMed  Google Scholar 

  50. Nakamura S, Iida M, Yao T, Fujishima M. Endoscopic features of gastric carcinoids. Gastrointest Endosc 1991;37:535–538.

    Article  CAS  PubMed  Google Scholar 

  51. Fruauff A, Irwin GA, Williams HC, Gold B. CT demonstration of gastric carcinoid. AJR Am J Roentgenol 1987;148:1276–1277.

    CAS  PubMed  Google Scholar 

  52. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995;90:338–352.

    CAS  PubMed  Google Scholar 

  53. Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion 1995;56:455–462.

    Article  CAS  PubMed  Google Scholar 

  54. Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia: a prospective follow-up study. Scand J Gastroenterol 1998;33:88–92.

    Article  CAS  PubMed  Google Scholar 

  55. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996;20:168–172.

    Article  CAS  PubMed  Google Scholar 

  56. Moore NR, Rogers CE, Britton BJ. Magnetic resonance imaging of endocrine tumours of the pancreas. Bri J Radiol 1995;68:341–347.

    Article  CAS  Google Scholar 

  57. Pelley RJ, Bukowski RM. Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 1997;9:68–74.

    Article  CAS  PubMed  Google Scholar 

  58. MacFarlane MP, Fraker DL, Alexander HR, Norton JA, Lubensky I, Jensen RT. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 1995;118:973–979.

    CAS  PubMed  Google Scholar 

  59. Thom AK, Norton JA, Axiotis CA, Jensen RT. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery 1991;110:1086–1091.

    CAS  PubMed  Google Scholar 

  60. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel G. Surgical pathology of gastrinoma: site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 1991;68:1329–1334.

    CAS  PubMed  Google Scholar 

  61. Frucht H, Norton JA, London JF, et al. Detection of duodenal gastrinomas by operative endoscopic transillumination: a prospective study. Gastroenterology 1990;99:1622–1627.

    CAS  PubMed  Google Scholar 

  62. Schirmer WJ, Melvin WS, Rush RM, et al. Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. Surgery 1995;118:1105–1113.

    CAS  PubMed  Google Scholar 

  63. Sugg SL, Norton JA, Fraker DL, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993;218:138–144.

    CAS  PubMed  Google Scholar 

  64. Proye C, Pattou F, Carnaille B, Paris JC, d’Herbomez M, Marchandise X. Intraoperative gastrin measurements during surgical management of patients with gastrinomas: experience with 20 cases. World J Surg 1998;22:643–649.

    Article  CAS  PubMed  Google Scholar 

  65. Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg 1996;20:173–182.

    Article  CAS  PubMed  Google Scholar 

  66. Wheeler MH, Curley IR, Williams ED. The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 1986;100:1163–1169.

    CAS  PubMed  Google Scholar 

  67. Fuller CE, Williams GT. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen’s disease). Histopathology 1991;19:1–11.

    CAS  PubMed  Google Scholar 

  68. Kloppel G, Heitz PU, Capella C, Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg 1996;20:132–141.

    Article  CAS  PubMed  Google Scholar 

  69. Neoptolemos JR, Talbot IC, Shaw DC, Carr-Locke DL. Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 1988;61:1403–1407.

    CAS  PubMed  Google Scholar 

  70. Maurer CA, Baer HU, Dyong TH, et al. Carcinoid of the pancreas: clinical characteristics and morphological features. Eur J Cancer 1996;32A:1109–1116.

    Article  CAS  PubMed  Google Scholar 

  71. Moertel CG, Hanley JA. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials 1979;2:327–334.

    CAS  PubMed  Google Scholar 

  72. Feldman JM. Carcinoid tumors and the carcinoid syndrome. Curr Probl Surg 1989;26:835–885.

    Article  CAS  PubMed  Google Scholar 

  73. Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997;79:1086–1093.

    Article  CAS  PubMed  Google Scholar 

  74. Weber JD, McFadden DW. Carcinoid tumors in Meckel’s diverticula. J Clin Gastroenterol 1989;11:682–686.

    CAS  PubMed  Google Scholar 

  75. Makridis C, Rastad J, Oberg K, Akerstrom G. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg 1996;20:900–906.

    Article  CAS  PubMed  Google Scholar 

  76. Basson MD, Ahlman H, Wangberg B, Modlin IM. Biology and management of the midgut carcinoid. Am J Surg 1993;165:288–297.

    CAS  PubMed  Google Scholar 

  77. Orlefors H, Sundin A, Ahlstrom H, et al. Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors. J Clin Oncol 1998;16:2534–2541.

    CAS  PubMed  Google Scholar 

  78. Woodard PK, Feldman JM, Paine SS, Baker ME. Midgut carcinoid tumors: CT findings and biochemical profiles. J Comput Assist Tomogr 1995;19:400–405.

    CAS  PubMed  Google Scholar 

  79. Wallace S, Ajani JA, Charnsangavej C, et al. Carcinoid tumors: imaging procedures and interventional radiology. World J Surg 1996;20:147–156.

    Article  CAS  PubMed  Google Scholar 

  80. Sugimoto E, Lorelius LE, Eriksson B, Oberg K. Midgut carcinoid tumours: CT appearance. Acta Radiol 1995;36:367–371.

    Article  CAS  PubMed  Google Scholar 

  81. Ahlman H, Nilsson O, Wangberg B, Dahlstrom A. Neuroendocrine insights from the laboratory to the clinic. Am J Surg 1996;172:61–67.

    Article  CAS  PubMed  Google Scholar 

  82. Ohrvall U, Westlin JE, Nilsson S, et al. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 1997;80:2490–2494.

    Article  CAS  PubMed  Google Scholar 

  83. Wangberg B, Westberg G, Tylen U, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 1996;20:892–899.

    Article  CAS  PubMed  Google Scholar 

  84. Persson BG, Nobin A, Ahren B, Jeppsson B, Mansson B, Bengmark S. Repeated hepatic ischemia as a treatment for carcinoid liver metastases. World J Surg 1989;13:307–311.

    Article  CAS  PubMed  Google Scholar 

  85. Ahlman H, Westberg G, Wangberg B, et al. Treatment of liver metastases of carcinoid tumors. World J Surg 1996;20:196–202.

    Article  CAS  PubMed  Google Scholar 

  86. Box JC, Watne AL, Lucas GW. Small bowel carcinoid: review of a single institution experience and review of the literature. Am Surg 1996;62:280–286.

    CAS  PubMed  Google Scholar 

  87. Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol 1998;93:422–428.

    Article  CAS  PubMed  Google Scholar 

  88. Roggo A, Wood WC, Ottinger LW. Carcinoid tumors of the appendix. Ann Surg 1993;217:385–390.

    CAS  PubMed  Google Scholar 

  89. Stinner B, Kisker O, Zielke A, Rothmund M. Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg 1996;20:183–188.

    Article  CAS  PubMed  Google Scholar 

  90. Rosenberg JM, Welch JP. Carcinoid tumors of the colon: a study of 72 patients. Am J Surg 1985;149:775–779.

    CAS  PubMed  Google Scholar 

  91. Tobi M, Darmon E, Rozen P, et al. Shared tumor antigens in colorectal carcinoma and neuroendocrine tumors. Cancer Detect Prev 1998;22:147–152.

    Article  CAS  PubMed  Google Scholar 

  92. Federspiel BH, Burke AP, Sobin LH, Shekitka KM. Rectal and colonic carcinoids: a clinicopathologic study of 84 cases. Cancer 1990;65:135–140.

    CAS  PubMed  Google Scholar 

  93. Soga J. Carcinoids of the rectum: an evaluation of 1271 reported cases. Surg Today 1997;27:112–119.

    Article  CAS  PubMed  Google Scholar 

  94. Jetmore AB, Ray JE, Gathright JB Jr, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992;35:717–725.

    Article  CAS  PubMed  Google Scholar 

  95. Sauven P, Ridge JA, Quan SH, Sigurdson ER. Anorectal carcinoid tumors: is aggressive surgery warranted? Ann Surg 1990;211:67–71.

    CAS  PubMed  Google Scholar 

  96. Higaki S, Nishiaki M, Mitani N, Yanai H, Tada M, Okita K. Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy 1997;29:171–175.

    Article  CAS  PubMed  Google Scholar 

  97. Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg 1994;179:231–248.

    CAS  PubMed  Google Scholar 

  98. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998;187:88–92.

    Article  CAS  PubMed  Google Scholar 

  99. Winkelbauer FW, Niederle B, Pietschmann F, et al. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil. AJR Am J Roentgenol 1995;165:323–327.

    CAS  PubMed  Google Scholar 

  100. Ajani JA, Carrasco CH, Wallace S. Neuroendocrine tumors metastatic to the liver: vascular occlusion therapy. Ann NY Acad Sci 1994;733:479–487.

    CAS  PubMed  Google Scholar 

  101. de Baere T, Roche A, Amenabar JM, et al. Liver abscess formation after local treatment of liver tumors. Hepatology 1996;23:1436–1440.

    Article  PubMed  Google Scholar 

  102. Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997;122:1147–1154.

    Article  CAS  PubMed  Google Scholar 

  103. Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery 1997;122:1040–1047.

    Article  CAS  PubMed  Google Scholar 

  104. Bongers V, de Klerk JM, Zonnenberg BA, de Kort G, Lips CJ, van Rijk PP. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors. J Nucl Med 1997;38:1024–1026.

    CAS  PubMed  Google Scholar 

  105. Diaco DS, Hajarizadeh H, Mueller CR, Fletcher WS, Pommier RF, Woltering EA. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg 1995;169;523–528.

    Google Scholar 

  106. Ramage JK, Catnach SM, Williams R. Overview: the management of metastatic carcinoid tumors. Liver Transpl Surg 1995;1:107–110.

    Article  CAS  PubMed  Google Scholar 

  107. Routley D, Ramage JK, McPeake J, Tan KC, Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg 1995;1:118–121.

    Article  CAS  PubMed  Google Scholar 

  108. Dousset B, Houssin D, Soubrane O, Boillot O, Baudin F, Chapuis Y. Metastatic endocrine tumors: is there a place for liver transplantation? Liver Transpl Surg 1995;1:111–117.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Keith W. Millikan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward F. Hollinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rush Medical College, Chicago, IL, 60612, USA

    Theodore J. Saclarides M.D. (Professor of Surgery, Head), Keith W. Millikan M.D. (Associate Professor of Surgery, Director of Undergraduate Surgical Education, Director) & Constantine V. Godellas M.D. (Associate Professor of Surgery, Academic Program Coordinator) (Professor of Surgery, Head),  (Associate Professor of Surgery, Director of Undergraduate Surgical Education, Director) &  (Associate Professor of Surgery, Academic Program Coordinator)

  2. Section of Colon and Rectal Surgery Department of General Surgery, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL, 60612, USA

    Theodore J. Saclarides M.D. (Professor of Surgery, Head) (Professor of Surgery, Head)

  3. Nutrition Consultation Service Department of General Surgery, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL, 60612, USA

    Keith W. Millikan M.D. (Associate Professor of Surgery, Director of Undergraduate Surgical Education, Director) (Associate Professor of Surgery, Director of Undergraduate Surgical Education, Director)

  4. Department of General Surgery, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL, 60612, USA

    Constantine V. Godellas M.D. (Associate Professor of Surgery, Academic Program Coordinator) (Associate Professor of Surgery, Academic Program Coordinator)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Millikan, K.W., Hollinger, E.F. (2003). Carcinoid Tumors. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_16

Download citation

  • DOI: https://doi.org/10.1007/0-387-21701-0_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95201-7

  • Online ISBN: 978-0-387-21701-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation